🚀 Today’s Healthcare Tech Highlights — August 8, 2025
1. AI Gives Early Warning for Deadliest Brain Cancer
News‑Medical reports UVa’s AI-powered imaging tool can distinguish tumor growth from treatment effects in glioblastoma patients with 74% accuracy—much faster than the months it currently takes. This isn’t sci-fi—it’s game-changing for urgent, life-saving decisions. ()
2. AI in Radiology Grows at Nearly 20% Annually
AI in Radiology Market Report shows the field’s explosive growth—AI tools for imaging are projected to surge with a CAGR of 18.25%, reaching over **$5 billion** by 2032. Demand is skyrocketing for precision and speed in diagnostics. [oai_citation:0‡Axios](https://www.axios.com/2025/08/06/ai-chatbots-mental-health-state-laws?utm_source=chatgpt.com)
3. Survivor Tracking System to Now Cover Entire New Jersey
PR Newswire announces InVita’s Track‑Kit™ will become New Jersey’s statewide sexual assault kit tracking system—offering survivors real-time visibility on kit status, DNA processing, and investigative progress. Better transparency, better justice. [oai_citation:1‡Business Insider](https://www.businessinsider.com/healthcare-startups-using-ai-see-more-patients-chase-profits-2025-7?utm_source=chatgpt.com)
4. Cambridge Innovates Inhaler Tech That Actually Works
The Times covers Cambridge Healthcare Innovations’ Quattrii dry‑powder inhaler. While legacy inhalers lose up to 90% of medicine to inefficiency, Quattrii delivers over 70% of the dose directly to the lungs. Built on a shoestring budget (~£2M) and ready for Phase 1 trials this fall, this is a classic underdog story with blockbuster potential. ()
Why It Matters
- Smarter brain cancer care: UVa’s AI speeds up glioblastoma treatment decisions—a win for both care quality and provider confidence.
- Radiology goes big: With an 18% CAGR, AI in imaging isn’t just growth—it’s a revolution in diagnostics infrastructure.
- Survivor-centric tech: New Jersey’s system puts power directly in survivors’ hands—transparency matters and Track‑Kit³ by InVita delivers.
- Inhaler breakthrough: Quattrii disrupts 70+ years of neglect in respiratory drug delivery—efficiency that could change the game for pulmonary therapies.
